As of 2026-06-20, the Relative Valuation of Cortexyme Inc (CRTX) is (27.25) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.95 USD, the upside of Cortexyme Inc based on Relative Valuation is -1497.5%.
The range of the Relative Valuation is (25.24) - (29.06) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.7x - 23.4x | 20.0x |
| Forward P/E multiples | 18.5x - 21.3x | 19.9x |
| Fair Price | (25.24) - (29.06) | (27.25) |
| Upside | -1394.3% - -1590.2% | -1497.5% |
| Date | P/E |